Cargando…

Editorial: Current approaches in infectious disease drug discovery

Detalles Bibliográficos
Autores principales:	Silva-Jr, Floriano P., Panda, Siva S., Andrade, Carolina Horta, Furnham, Nicholas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748688/ https://www.ncbi.nlm.nih.gov/pubmed/36531321 http://dx.doi.org/10.3389/fchem.2022.1102402

Ejemplares similares

In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery
por: de Souza Neto, Lauro Ribeiro, et al.
Publicado: (2020)

Metabolomics in infectious diseases and drug discovery
por: Tounta, Vivian, et al.
Publicado: (2021)

Editorial: Cheminformatics Approaches in Drug Discovery for Neglected Tropical Diseases
por: Scotti, Luciana, et al.
Publicado: (2021)

Editorial: Computational Approaches in Drug Discovery and Precision Medicine
por: Huang, Zunnan, et al.
Publicado: (2021)

Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence
por: Moreira-Filho, José T., et al.
Publicado: (2021)

Computationally-guided drug repurposing enables the discovery of kinase targets and inhibitors as new schistosomicidal agents
por: Giuliani, Sandra, et al.
Publicado: (2018)

Editorial: In silico Methods for Drug Design and Discovery
por: Brogi, Simone, et al.
Publicado: (2020)

Editorial: Advances in green synthesis for drug discovery
por: Allais, Florent, et al.
Publicado: (2023)

Editorial: Protein–Protein Interactions: Drug Discovery for the Future
por: Rapposelli, Simona, et al.
Publicado: (2021)

Editorial: Peptidomimetics: Synthetic Tools for Drug Discovery and Development
por: Del Gatto, Annarita, et al.
Publicado: (2021)

Editorial: Advances in drug discovery for anti-Alzheimer’s agents
por: Ismaili, Lhassane
Publicado: (2022)

Editorial: Advances in natural product chemistry: Yunnan University 100th anniversary
por: Chen, Wen, et al.
Publicado: (2023)

Current challenges in peptide-based drug discovery
por: Otvos, Laszlo, et al.
Publicado: (2014)

Editorial: Discovery and Development of Drugs for Neglected Diseases: Chagas Disease, Human African Trypanosomiasis, and Leishmaniasis
por: Rivera, Gildardo, et al.
Publicado: (2021)

Editorial: Computational Drug Discovery for Targeting of Protein-Protein Interfaces
por: Meli, Massimiliano, et al.
Publicado: (2021)

Editorial: Application of PROTACs as a Novel Strategy for Drug Discovery
por: Ibrahim, Hany S., et al.
Publicado: (2021)

Editorial: Computer-aided drug design: Drug discovery, computational modelling, and artificial intelligence
por: Ye, Fei, et al.
Publicado: (2022)

A critical overview of computational approaches employed for COVID-19 drug discovery
por: Muratov, Eugene N., et al.
Publicado: (2021)

Drug repurposing: a better approach for infectious disease drug discovery?
por: Law, G Lynn, et al.
Publicado: (2013)

Editorial: Computational drug discovery for targeting of protein-protein interfaces—Volume II
por: Morra, Giulia, et al.
Publicado: (2023)

Covalent inhibitors: a rational approach to drug discovery
por: Sutanto, Fandi, et al.
Publicado: (2020)

Computational Approaches in Preclinical Studies on Drug Discovery and Development
por: Wu, Fengxu, et al.
Publicado: (2020)

Effect of “magic chlorine” in drug discovery: an in silico approach
por: Joshi, Sravani, et al.
Publicado: (2023)

Editorial: Current Analytical Trends in Drug Testing in Clinical and Forensic Toxicology
por: Gallardo, Eugenia, et al.
Publicado: (2021)

OpenZika: An IBM World Community Grid Project to Accelerate Zika Virus Drug Discovery
por: Ekins, Sean, et al.
Publicado: (2016)

Editorial: Innovative approaches in drug discovery and development
por: Ramadan, Qasem, et al.
Publicado: (2023)

Is it time for biocatalysis in fragment-based drug discovery?
por: Ramsden, Jeremy I., et al.
Publicado: (2020)

Glycans in drug discovery
por: Valverde, Pablo, et al.
Publicado: (2019)

Mycobacterial drug discovery
por: Abrahams, Katherine A., et al.
Publicado: (2020)

Editorial: Current research on serological analyses of infectious diseases
por: Rogier, Eric William, et al.
Publicado: (2023)

Editorial: Multi-Target-Directed Ligands (MTDL) as Challenging Research Tools in Drug Discovery: From Design to Pharmacological Evaluation
por: Alcaro, Stefano, et al.
Publicado: (2019)

Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases
por: Li, Kai, et al.
Publicado: (2014)

From plant to cancer drug: lessons learned from the discovery of taxol
por: Cech, Nadja B., et al.
Publicado: (2023)

Editorial: Multiscale computational approaches in infectious diseases
por: Hernandez-Vargas, Esteban A., et al.
Publicado: (2022)

Facile synthetic approach towards vasorelaxant active 4-hydroxyquinazoline-4-carboxamides
por: Aziz, Marian N., et al.
Publicado: (2019)

Editorial: Current trends in the applications of bioluminescence
por: Wang, Lijuan, et al.
Publicado: (2023)

Discovery of new Schistosoma mansoni aspartyl protease inhibitors by structure-based virtual screening
por: Gomes, Bárbara Figueira, et al.
Publicado: (2023)

Editorial: Discovery of Novel Molecules for Corrosion Protection Using Computational Chemistry
por: Obot, Ime B., et al.
Publicado: (2018)

QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery
por: Neves, Bruno J., et al.
Publicado: (2018)

Artificial intelligence methods to repurpose and discover new drugs to fight the Coronavirus disease-2019 pandemic
por: Santana, Marcos V.S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r42h6d27fe3itnv9hgr98pmh9s